BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9195206)

  • 21. [Status of the sympatho-adrenal system in patients with diabetes mellitus: dependence on the course of the disease and the presence of late complications].
    Chandrashekar-Reddi KM; Balabolkin MI; Stoilov LD
    Probl Endokrinol (Mosk); 1994; 40(6):13-4. PubMed ID: 7740027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Homocysteine concentrations in patients with diabetes mellitus--relationship to microvascular and macrovascular disease.
    Elias AN; Eng S
    Diabetes Obes Metab; 2005 Mar; 7(2):117-21. PubMed ID: 15715884
    [No Abstract]   [Full Text] [Related]  

  • 23. Differential distribution of type IV collagen chains in patients with diabetic nephropathy in non-insulin-dependent diabetes mellitus.
    Yagame M; Kim Y; Zhu D; Suzuki D; Eguchi K; Nomoto Y; Sakai H; Groppoli T; Steffes MW; Mauer SM
    Nephron; 1995; 70(1):42-8. PubMed ID: 7617116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Basement membrane components (7S collagen, laminin P1) are increased in sera of diabetics and activate platelets in vitro.
    Högemann B; Balleisen L; Rauterberg J; Voss B; Gerlach U
    Haemostasis; 1986; 16(6):428-32. PubMed ID: 3583098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study.
    Savage S; Estacio RO; Jeffers B; Schrier RW
    Proc Assoc Am Physicians; 1997 Mar; 109(2):181-9. PubMed ID: 9069587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The relationship between concentration of growth hormone in serum and microangiopathy in patients with diabetes mellitus].
    Chen M; Yu W; Hu S
    Zhonghua Yi Xue Za Zhi; 1997 Oct; 77(10):765-7. PubMed ID: 9772523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Collagen binding activity in sera of patients with insulin-dependent (type 1) and non insulin-dependent (type 2) diabetes mellitus.
    Triolo G; Giardina E; Bompiani GD
    J Clin Lab Immunol; 1988 Jul; 26(3):121-4. PubMed ID: 3230579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased serum levels of advanced glycation end products in NIDDM patients with diabetic complications.
    Ono Y; Aoki S; Ohnishi K; Yasuda T; Kawano K; Tsukada Y
    Diabetes Care; 1998 Jun; 21(6):1027. PubMed ID: 9614627
    [No Abstract]   [Full Text] [Related]  

  • 29. Plasma levels of tissue factor antigen in patients with non-insulin-dependent diabetes mellitus.
    Song KS; Kim HK
    Yonsei Med J; 2004 Feb; 45(1):38-42. PubMed ID: 15004866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relation between the serum level of C-peptide and risk factors for coronary heart disease and diabetic microangiopathy in patients with type-2 diabetes mellitus.
    Inukai T; Matsutomo R; Tayama K; Aso Y; Takemura Y
    Exp Clin Endocrinol Diabetes; 1999; 107(1):40-5. PubMed ID: 10077354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prostacyclin-like activity modifying plasma factors in diabetic microangiopathy].
    Magyari M; Túri S; Csanálosi-Németh M
    Fortschr Ophthalmol; 1990; 87(3):269-73. PubMed ID: 2115854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma endothelin-1 concentrations in non-insulin-dependent diabetes mellitus and nondiabetic patients with chronic arterial obstructive disease of the lower limbs.
    Mangiafico RA; Malatino LS; Santonocito M; Spada RS
    Int Angiol; 1998 Jun; 17(2):97-102. PubMed ID: 9754897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coronary microangiopathy in type 2 diabetic patients: relation to glycemic control, sex, and microvascular angina rather than to coronary artery disease.
    Yokoyama I; Yonekura K; Ohtake T; Yang W; Shin WS; Yamada N; Ohtomo K; Nagai R
    J Nucl Med; 2000 Jun; 41(6):978-85. PubMed ID: 10855621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The significance of determination of urinary type IV collagen concentrations from a random urine collection in patients with non-insulin dependent diabetes mellitus].
    Kotajima N; Fukumura Y; Obata K; Kobayashi I
    Rinsho Byori; 1998 Mar; 46(3):277-82. PubMed ID: 9564768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel advanced glycation index and its association with diabetes and microangiopathy.
    Sampathkumar R; Balasubramanyam M; Rema M; Premanand C; Mohan V
    Metabolism; 2005 Aug; 54(8):1002-7. PubMed ID: 16092048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rheological changes in diabetic microangiopathy.
    Negrean V; Suciu I; Sâmpelean D; Cozma A
    Rom J Intern Med; 2004; 42(2):407-13. PubMed ID: 15529630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary type IV collagen as a marker for early diabetic nephropathy.
    Kado S; Aoki A; Wada S; Katayama Y; Kugai N; Yoshizawa N; Nagata N
    Diabetes Res Clin Pract; 1996 Mar; 31(1-3):103-8. PubMed ID: 8792108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased plasma urotensin-II levels are associated with diabetic retinopathy and carotid atherosclerosis in Type 2 diabetes.
    Suguro T; Watanabe T; Kodate S; Xu G; Hirano T; Adachi M; Miyazaki A
    Clin Sci (Lond); 2008 Dec; 115(11):327-34. PubMed ID: 18338983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum concentrations of intact type IV collagen in diabetics.
    Matsumoto E; Matsumoto G; Bessho H; Kikuoka H; Nanjo K
    J Diabet Complications; 1991; 5(2-3):189-90. PubMed ID: 1770042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased plasma endothelin levels in patients with insulin-dependent diabetes mellitus and end-stage vascular complications.
    Kirilov G; Dakovska L; Borisova AM; Krivoshiev S; Nentchev N
    Horm Metab Res; 1994 Feb; 26(2):119-20. PubMed ID: 8200615
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.